Clinical trials are a very important part of medical research.
Our trials help researchers discover new effective treatments for mental health disorders such as depression, bipolar disorder, schizophrenia and anxiety; where we not only examine possible new medications for the alleviation of symptoms, but also alternative treatments, such as new psychotherapy techniques.
If you have questions about any particular study or participation in general, please contact the study co-ordinator or our main office.
EMMAC study
The EMMAC study will assess the effect of MDMA and supportive talk therapy on depression and anxiety symptoms in patients with advanced stage cancer.
We are now recruiting patients for this study. Please contact the Principal Investigator, Professor Paul Glue if you are interested.
Read the provider information on the EMMAC study
Principal investigator
Professor Paul Glue Department of Psychological Medicine, Dunedin
Email paul.glue@otago.ac.nz
Ketamine-assisted mindfulness in Alcohol Use Disorder ( AUD )
Principal investigator
Dr Charlie MentzelDepartment of Psychological Medicine, Dunedin
Study co-ordinator
Grant Cooper
Email audket@otago.ac.nz
We are now recruiting participants by provider referral for this trial.
Read the provider information sheet (PDF)
Ketamine for people with treatment resistant anxiety
Principal investigator
Professor Bruce RussellUniversity of Otago School of Pharmacy
Study co-ordinators
Professor Paul Glue
Email paul.glue@otago.ac.nz
Collaborators
We are now recruiting patients for this trial.
Ketamine for treatment-resistant obsessive compulsive disorder (OCD)
Principal investigator
Professor Paul Glue
Department of Psychological Medicine, Dunedin
Study co-ordinator
Dr Shona Neehoff
Email shona.neehoff@otago.ac.nz
Collaborators
- Department of Anatomy
- Department of Psychology
- University of Otago School of Pharmacy
- Department of Psychological Medicine, Christchurch
We are now recruiting patients for this trial who live in either Dunedin or Christchurch.
Development of novel ketamine formulations
Study co-ordinator
Professor Paul Glue
Email paul.glue@otago.ac.nz